Aripiprazole Use Combined With Depot Antipsychotic Medication: Two Cases Demonstrating Its Ability to Reduce Prolactin Levels in an Adolescent Forensic Hospital

Therapeutic Advances in Psychopharmacology
doi 10.1177/2045125311409284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Financial Incentives for Antipsychotic Depot Medication: Ethical Issues

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2007English

Systematic Review of Patient and Nurse Attitudes to Depot Antipsychotic Medication

British Journal of Psychiatry
MedicinePsychiatryMental Health
2001English

Treatment Adherence and Social Functioning in Patients Diagnosed With Schizophrenia and Treated With Antipsychotic Depot Medication

Medicine and Pharmacy Reports
Medicine
2014English

Combining Depot Antipsychotic Medications With Novel Antipsychotics in Forensic Patients: A Practice in Search of a Principle

Psychiatric Bulletin
2003English

Use of High Dose Antipsychotic Medication

Psychiatric Bulletin
1997English

Evaluating the Use of Enforced Clozapine in an Australian Forensic Psychiatric Setting: Two Cases

BMC Psychiatry
PsychiatryMental Health
2007English

Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients With Schizophrenia

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2012English

Use of Psychotropic Medication in an Adolescent In-Patient Unit

Psychiatric Bulletin
1998English

A Prospective Observational Study on Comparison of Lurasidone Versus Aripiprazole Based on Serum Prolactin Levels in a Tertiary Care Teaching Hospital

Journal of Evidence Based Medicine and Healthcare
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy